Enhanced Oral Bioavailability of MT-102, a New Anti-inflammatory Agent, via a Ternary Solid Dispersion Formulation

Enhanced Oral Bioavailability of MT-102, a New Anti-inflammatory Agent, via a Ternary Solid Dispersion Formulation

This study aimed to develop a solid dispersion (SD) of MT-102, a new anti-inflammatory agent, to improve its oral bioavailability. The ternary SD formulations of MT-102 (a poorly soluble extract of <i>Isatis indigotica</i> and <i>Juglans mandshurica</i>) were prepared using a...

Full description

Bibliographic Details
Main Authors: Rajiv Bajracharya, Jae Geun Song, Sang Hoon Lee, Seong Hoon Jeong, Hyo-Kyung Han
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Pharmaceutics
Subjects:
MT-102
solid dispersion
dissolution
indirubin
poloxamer 407
povidone K30
Online Access:https://www.mdpi.com/1999-4923/14/7/1510

Internet

https://www.mdpi.com/1999-4923/14/7/1510

Similar Items